New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
15:51 EDTCAHEarnings Preview: Cardinal Health breaks short term uptrend into Q2 report
Cardinal Health (CAH) is scheduled to report Q2 earnings before the market open on Tuesday February 5, with a conference call scheduled for 8:30 am ET. Cardinal Health improves the cost-effectiveness of healthcare. As the business behind healthcare, Cardinal Health helps pharmacies, hospitals and ambulatory care sites focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability... EXPECTATIONS: Analysts are looking for EPS of 86c on revenue of $24.61B, according to First Call. The consensus range for EPS is 84c-88c on revenue of $24.22B-$25.04B... LAST QUARTER: Cardinal Health reported Q1 EPS of 81c against estimates of 79c on revenue of revenue $25.89B, against estimates of $26.35B. At the time of its Q1 results, Cardinal Health gave FY13 EPS guidance of $3.35-$3.50 on analysts consensus estimates of $3.45. The company backed that EPS view at the for J.P. Morgan Healthcare Conference on January 8... STREET RESEARCH: On January 23, RW Baird raised its price target on Cardinal Health shares to $52 from $50, citing earnings leverage, continued generics contributions, growth in platforms outside of drug distribution, and share repurchases. The firm has an Outperform rating on shares of the company... PRICE ACTION: Shares of Cardinal Health have traded lower, after announcing on January 30 that it expects to incur a $79M restructuring charge from a medical segment reorganization. In late afternoon trading, shares of Cardinal Health are trading down less than a percentage point at $43.66.
News For CAH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
11:32 EDTCAHCardinal Health to pay $26.8M to settle FTC charges
In its latest action to ensure competition in the nationís healthcare markets, the FTC announced that Cardinal Health has agreed to resolve charges that it illegally monopolized 25 local markets for the sale and distribution of low-energy radiopharmaceuticals and forced hospitals and clinics to pay inflated prices for these drugs. The proposed stipulated order requires Cardinal to pay $26.8M of ill-gotten gains and represents the second largest monetary settlement the FTC has obtained in an antitrust case. The money will be deposited into a fund for distribution to injured customers. The order also includes provisions to prevent future violations and restore competition in six markets where Cardinal remains the dominant radiopharmacy. Reference Link
April 16, 2015
07:05 EDTCAHNovaBay signs distribution agremeent with AmerisourceBergen
Subscribe for More Information
April 15, 2015
10:36 EDTCAHBofA/Merrill U.S. credit analysts hold an analyst/industry conference call
Subscribe for More Information
April 13, 2015
14:07 EDTCAHEarnings Watch: Johnson & Johnson shares down slightly since last earnings
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use